These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2444078)

  • 1. Effects of PGI2 analog iloprost on myocardial infarct size, regional myocardial blood flow, and platelet function in rabbits with coronary artery occlusion followed by reperfusion.
    Golino P; Cappelli-Bigazzi M; Perrone-Filardi P; Nevola E; Quattrin S; Salvatore M; Chiariello M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():377-80. PubMed ID: 2444078
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.
    Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M
    Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial ischaemia and reperfusion in the anaesthetised pig: reduction of infarct size and myocardial enzyme release by the stable prostacyclin analogue iloprost.
    Stürzebecher S; McDonald FM; Grundmann G; Hartmann S; Lammert C
    Prog Clin Biol Res; 1989; 301():155-9. PubMed ID: 2477850
    [No Abstract]   [Full Text] [Related]  

  • 4. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
    Kanayama T; Kimura Y; Mizogami S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):344-9. PubMed ID: 7687292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a thromboxane synthetase inhibitor in circumflex coronary artery occlusion and reperfusion.
    Huddleston CB; Lupinetti FM; Clanton J; Collins J; Oates JA; Hammon JW
    Curr Surg; 1983; 40(3):211-5. PubMed ID: 6683615
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion.
    Kelly RF; Hursey TL; Schaer GL; Piotrowski MJ; Dee SV; Parrillo JE; Hollenberg SM
    J Investig Med; 1996 Dec; 44(9):575-82. PubMed ID: 9035612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduction of myocardial occlusion-reperfusion necrosis by the administration of a stable prostacyclin analog in the rabbit].
    Golino P; Tritto I; Vallone C; Prota S; Salvatore M; Chiariello M
    Cardiologia; 1988 Apr; 33(4):381-4. PubMed ID: 2457441
    [No Abstract]   [Full Text] [Related]  

  • 9. Pacing-induced dyssynchrony during early reperfusion reduces infarct size.
    Vanagt WY; Cornelussen RN; Baynham TC; Van Hunnik A; Poulina QP; Babiker F; Spinelli J; Delhaas T; Prinzen FW
    J Am Coll Cardiol; 2007 May; 49(17):1813-9. PubMed ID: 17466233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
    Heusch G; Skyschally A; Gres P; van Caster P; Schilawa D; Schulz R
    Eur Heart J; 2008 Sep; 29(18):2265-75. PubMed ID: 18621770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocardial and epicardial infarct size after preconditioning by a partial coronary artery occlusion without intervening reperfusion. Importance of the degree and duration of flow reduction.
    Koning MM; Gho BC; van Klaarwater E; Duncker DJ; Verdouw PD
    Cardiovasc Res; 1995 Dec; 30(6):1017-27. PubMed ID: 8746219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    Circ Res; 1987 May; 60(5):666-73. PubMed ID: 2439229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
    Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet reactivity in unstable coronary artery disease.
    Swahn E; Wallentin L
    Thromb Haemost; 1987 Jun; 57(3):302-5. PubMed ID: 2958954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the thromboxane synthetase inhibitor dazoxiben and the prostacyclin mimetic iloprost in an animal model of acute ischaemia and reperfusion.
    Thiemermann C; Schrör K
    Biomed Biochim Acta; 1984; 43(8-9):S151-4. PubMed ID: 6083783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion.
    Golino P; Maroko PR; Carew TE
    Circulation; 1987 Jul; 76(1):173-80. PubMed ID: 3594766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.